SANGAMO THERAPEUTICS INC
SGMO
SGMO was delisted on the 4th of May, 2026.
217 hedge funds and large institutions have $1.1B invested in SANGAMO THERAPEUTICS INC in 2018 Q3 according to their latest regulatory filings, with 35 funds opening new positions, 74 increasing their positions, 57 reducing their positions, and 28 closing their positions.
30% more repeat investments, than reductions
Existing positions increased: 74 | Existing positions reduced: 57
25% more first-time investments, than exits
New positions opened: 35 | Existing positions closed: 28
19% more capital invested
Capital invested by funds: $919M → $1.1B (+$178M)
3% more funds holding
Funds holding: 210 → 217 (+7)
0% more call options, than puts
Call options by funds: $36.1M | Put options by funds: $36M
0% more funds holding in top 10
Funds holding in top 10: 2 → 2 (0)
0.09% less ownership
Funds ownership: 63.79% → 63.7% (-0.09%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Wellington Management Group
Boston,
Massachusetts
|
+$15.5M |
| 2 |
Goldman Sachs
New York
|
+$9.13M |
| 3 |
CC
Casdin Capital
New York
|
+$9.12M |
| 4 |
WA
Wasatch Advisors
Salt Lake City,
Utah
|
+$7.39M |
| 5 |
Millennium Management
New York
|
+$6.81M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Adage Capital Partners
Boston,
Massachusetts
|
-$28.1M |
| 2 |
EC
EcoR1 Capital
San Francisco,
California
|
-$17.7M |
| 3 |
NC
Nexthera Capital
New York
|
-$15.2M |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
-$10.4M |
| 5 |
Fidelity Investments
Boston,
Massachusetts
|
-$10.1M |
SGMO Hedge Fund Activity: Q3 2018 in Review
217 of the 4,375 institutional investors tracked by Wall St. Rank reported a position in SANGAMO THERAPEUTICS INC (SGMO) for Q3 2018, worth a combined $1.1B — up 19% from $919M a quarter earlier.
Buyers outnumbered sellers: 35 funds opened new SGMO positions and 28 closed out — a net gain of 7 holders — while 74 added to existing stakes and 57 trimmed.
The largest buyer was Wellington Management Group, adding an estimated $15.5M. The largest seller was Adage Capital Partners, cutting an estimated $28.1M.
- 217 institutional investors held SANGAMO THERAPEUTICS INC (SGMO) as of Q3 2018, up from 210 in Q2 2018.
- Funds reported $1.1B of SANGAMO THERAPEUTICS INC stock for Q3 2018, up 19% quarter-over-quarter.
- 35 funds opened new SANGAMO THERAPEUTICS INC positions in Q3 2018 and 28 closed out, a net change of +7 holders.
- The largest SANGAMO THERAPEUTICS INC buyer in Q3 2018 was Wellington Management Group, an estimated $15.5M added.
- The largest SANGAMO THERAPEUTICS INC seller in Q3 2018 was Adage Capital Partners, an estimated $28.1M sold.
Based on aggregated 13F filings for Q3 2018.